RBC Capital Reiterates Outperform on Biohaven, Maintains $61 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Leonid Timashev has reiterated an Outperform rating on Biohaven (NYSE:BHVN) and maintained a $61 price target on the stock.
April 09, 2024 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Leonid Timashev reaffirmed an Outperform rating on Biohaven with a $61 price target.
The reaffirmation of the Outperform rating and the maintenance of a $61 price target by a reputable analyst like Leonid Timashev could instill confidence among investors and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100